Conferences

2022

More Than Neurons III: Changing the Paradigm for Novel Therapeutic Avenues, 15-17 December 2022, Turin, Italy

• Platform presentation: Dr Monika Myszczynska “Uncovering new targets and therapies for amyotrophic lateral sclerosis (ALS) using artificial intelligence (AI) approaches”

Cell Symposium: Advances in Therapeutic Applications of Stem Cells, 8-10 December 2022, Cedars-Sinai, Los Angeles, CA, USA

• Poster: Dr Cleide Dos Santos Souza “Mechanisms of neuronal vulnerability and resilience in Amyotrophic Lateral Sclerosis (ALS): The role of striatum”
• Poster: Dr Raquel Rua Martins “M102, a potential multi-target drug for the treatment of amyotrophic lateral sclerosis” *Guarantors of Brain Travel Grant*

Development and 3D Modeling of the Human Brain, 7-10 December 2022, Cold Spring Harbor Laboratory, NY, United States

• Poster: Ana Aragon Gonzalez “Blood-Brain Barrier human-derived in vitro model: a valuable resource for researching neurological disorders dynamics and therapeutics” *Poster Prize*

• Poster: Jannigje Kok “Astrocyte-induced DNA damage as a mechanism of motor neuron death in ALS”

International Society for Stem Cell Research (ISSCR) Annual Meeting 15-19 June 2022, San Francisco, CA, United States

• Platform presentation: Dr Cleide dos Santos Souza “Decoding neuronal vulnerability and resilience in amyotrophic lateral sclerosis” *Abstract Merit Award*

17th Annual Medical School Research Meeting 13-14 June 2022, Sheffield, United Kingdom

• Platform presentation: Allan Shaw “Reprogrammed astrocytes from individuals with either C9orf72-mediated FTD or ALS display differential C9orf72 pathology and neurotoxicity”
• Poster: Katie Roome “An anti-inflammatory approach for the treatment of amyotrophic lateral sclerosis” *NC3R’s Poster Prize*

Gordon Research Conference – Barriers of the CNS: Translating Basic Knowledge About Brain Barriers into Treatments for Neurological Disorders 12-17 June 2022, New London, NH, United States

• Poster: Ana Aragon Gonzalez “Blood-brain barrier human in vitro model as a reliable tool for therapeutic applications”

European Network to Cure ALS (ENCALS) 1-3 June 2022, Edinburgh, United Kingdom

• Platform presentation: Jannigje Kok “Astrocyte-induced DNA damage as a mechanism of motor neuron death in ALS”
• Poster + rapid fire poster presentation: Andre Varcianna “Dysregulation of extracellular vesicle formation and release in astrocytes from ALS patients”
• Poster: Allan Shaw “Reprogrammed astrocytes from a C9-ALS family with variable penetrance display differential C9orf72 pathology and motor neuron toxicity in co-culture” *Poster Award*

Scholars International Neuroscience and Brain Disorders Forum  (NeuroForum 2022) 23-24 May, 2022, online event

• Invited talk: Dr Monika Myszczynska “Uncovering new targets and therapies for amyotrophic lateral sclerosis (ALS) using artificial intelligence (AI) approaches”